|
BRAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.372700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.351700E-02 |
| Normal-vs-Stage2 |
1.648570E-01 |
| Normal-vs-Stage3 |
4.443400E-03 |
| Normal-vs-Stage4 |
2.782400E-01 |
| Stage1-vs-Stage2 |
8.635600E-01 |
| Stage1-vs-Stage3 |
9.074100E-02 |
| Stage1-vs-Stage4 |
4.938800E-01 |
| Stage2-vs-Stage3 |
2.561600E-01 |
| Stage2-vs-Stage4 |
6.423200E-01 |
| Stage3-vs-Stage4 |
7.439800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.764000E-03 |
| Normal-vs-AfricanAmerican |
8.410300E-04 |
| Normal-vs-Asian |
3.809400E-01 |
| Caucasian-vs-AfricanAmerican |
1.270610E-01 |
| Caucasian-vs-Asian |
9.999600E-01 |
| AfricanAmerican-vs-Asian |
5.886000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.660100E-03 |
| Normal-vs-Female |
2.555100E-04 |
| Male-vs-Female |
1.590210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.977900E-02 |
| Normal-vs-Extreme_Weight |
4.414000E-01 |
| Normal-vs-Obese |
2.578900E-03 |
| Normal-vs-Extreme_Obese |
4.486800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.600600E-01 |
| Normal_Weight-vs-Obese |
2.811400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.543790E-01 |
| Extreme_Weight-vs-Obese |
1.980470E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.630800E-01 |
| Obese-vs-Extreme_Obese |
1.219580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.536000E-03 |
| Normal-vs-Age(41-60Yrs) |
7.87970000000193E-05 |
| Normal-vs-Age(61-80Yrs) |
5.134200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.731800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.774200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.754390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.420100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.993800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.158240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.964000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.206200E-04 |
| Normal-VS-Type2 PRCC |
2.664200E-01 |
| Normal-VS-KIRP CIMP |
5.253700E-02 |
| Normal-VS-Unclassified PRCC |
3.468500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.616210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.579000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.603000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.376400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.316000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.987400E-01 |
| Normal-vs-N1 |
4.539300E-03 |
| Normal-vs-N2 |
9.107800E-02 |
| N0-vs-N1 |
8.416800E-03 |
| N0-vs-N2 |
4.770400E-01 |
| N1-vs-N2 |
4.514200E-01 |
|
|
